HOW TO DECREASE YOUR RISK OF PROSTATE CANCER

By Michelle Haessler, M.D.

One in six men will develop prostate cancer in their lifetime. Whereas, many men will have a type of nonaggressive prostate cancer that is referred to as “low grade” and never need treatment, many will develop a more aggressive form of prostate cancer, which will require treatment.

This treatment could consist of hormonal treatment, surgery, radiation treatment or a combination of these modalities. These treatments can be costly not only financially but they can have numerous comorbidities associated with them. Wouldn’t it be preferable to never develop this disease?

Prostate cancer and numerous other cancers, are inversely related to UV light exposure. The more sunlight a person gets the lower the cancer rates. Even living closer to the equator lessens your risk of cancer. Also, prostate cancer mortality in the US has been shown to be lower with more UV exposure.  Why is this?  Vitamin D levels are higher with more UV exposure. Unfortunately, Americans are quite deficient on this vitamin.

The National Health and Nutrition Survey 2005-6 showed that overall in the U.S. 41.6% of Americans were deficient in this vitamin. African Americans fared the worst with 82.2% being deficient and Hispanics were 69.2% deficient. The reason is that people with more pigment in their skin absorb less sunlight and therefore less vitamin D is produced.

A study in Journal of Clinical Cancer Research took vitamin D blood samples from 700 men. Half were of European ancestry and half from African American ancestry. Low Vitamin D levels were associated with a more aggressive (higher grade) form of prostate cancer as well as a more advanced prostate cancer in all men. African Americans were also found to be at a higher overall risk of developing prostate cancer.

Another study presented at the 2005 American Chemical Society studied men with prostate cancer who choice to undergo prostatectomy with subsequent Vitamin D supplementation or active surveillance with the addition of Vitamin D. Men who had undergone surgery showed a decrease in inflammatory processes when they took vitamin D. Men who had undergone surveillance and Vitamin D supplementation at 1 year showed a decrease in the number of positive biopsy cores (less cancer) at repeat biopsy but no change in PSA.

What are the ways to get vitamin D?
The human body must obtain vitamin D from outside sources. Fortified milk products, fatty fish, mushrooms and egg yolks are the main sources of dietary supplementation. Sunshine is a good source and is actually the main source for humans. Whereas, sunshine is wonderful source, if you have darker skin you simply do not absorb as much and are most likely deficient in this vitamin. If you have light skin then you are at risk for skin cancer with excess sun exposure. As a matter of fact, there have been more skin cancers diagnosed in the last 30 years than all other cancer combined.

The answer is to supplement with vitamin D and get the levels up to a therapeutic level. I would recommend a blood level of 40-60ng/ml. As to decreasing skin cancers the answer is nicotinamide. In 2015 the New England Journal of Medicine published a randomized phase 3 study looking at taking nicotinamide at a certain dose twice a day. What they found was amazing. At one year the total amount of skin cancers was reduced by 23%, basal cell carcinomas were reduced by 20%, squamous cell carcinomas by 30% and actinic keratosis (precancers) by 11%.

An easy and convenient way to get both of these vitamins is in a new product CoVitale-7. It not only has the recommended doses of Vitamin D and Nicotinamide but also Curcumin which has been shown to decrease cell proliferation and piper nigrum which enhances its effects. CoVitale-7 was developed by The Ola Kino Company, LLC. The Co-Founders of The Ola Kino Company are Michelle Haessler M.D., a Board Certified Radiation Oncologist with more than 25 years in practice and Kacie Van Colen, RCPhT.

To learn more about the product and to purchase visit www.theolakinocompany.com

Michelle Haessler, M.D.
Board Certified Radiation Oncologist
Dr. Haessler is a Board Certified Radiation Oncologist. She has spent over 25 years diagnosing and treating cancer patients. At age 30 she decided to go to Medical School and become a physician. She was a single parent with a 3-year-old daughter. Her daughter provided motivation for her decision to become a physician. Dr. Haessler wanted to provide a good life for her daughter and prove to her that women can accomplish anything in life if they wanted it badly enough.

She graduated from the University of Nevada, Reno School of Medicine in 1989 and completed her internship in Internal Medicine the following year. While going through her oncology rotation she was inspired by her cancer patients. Their bravery and optimism against all odds , their love of life and all of the people around them, motivated Dr. Haessler to devote her life to helping these patients in any way she could.

She completed her Radiation Oncology residency at Henry Ford Hospital in 1994. She is most appreciative of the wonderful education and experience she received there. HFH is a world renown cancer center treating an endless variety of cancers from the rarest to the most common forms. She remembers the excellent, dedicated physicians she had the honor of working with.

Dr. Haessler has worked as a Radiation Oncologist in Nebraska and Iowa for approximately the last 17 years. While she was an Assistant Professor at Creighton University and elsewhere she gave numerous lectures on a variety of cancer topics including: breast cancer, prostate cancer, lung cancer, radiation oncology emergencies, radiobiology, advances in cancer treatments, palliative care etc. She loved teaching medical students, nurses, residents, her patients and anyone that wanted to listen.

Throughout all her experiences, Dr. Haessler has had a profound love for her patients and respect for all the hard work and dedication her fellow oncologists have had. After seeing so much heartbreak with the passing of terminally ill patients, Dr. Haessler usually could be heard after a long day uttering “I HATE CANCER”. She attended a lecture on the effects of vitamin D3 and its decrease in the risk of certain cancers and this then became Dr. Hassler’s next challenge in life to try to decrease the incidence of cancer.

New studies were published which showed that certain cancer risks might be decreased with simple daily supplements. After years of studying this and pondering how best to convey this information, Dr. Haessler decided to develop a nutritional supplement which taken twice daily may decrease the incidence of certain cancers, decrease the expense of cancer treatment, decrease the discomfort of treatment but  most importantly decrease the heartbreak of cancer itself, thus, the creation of Covitale-7.

CoVitale-7 can be purchased at:
Naples Pharmacy
848 1st Avenue North, Suite 120
Naples, FL 34102
(next to Wynn’s Market)